English | Español

Boehringer-Ingelheim
+ Technology/Innovation
Carol Ostrow | Dec 15, 2017

Boehringer Ingelheim collaborations yield vaccine technology, cancer treatments
+ Technology/Innovation
Ruth de Jauregui | Jun 14, 2017

Boehringer Ingelheim, Eli Lilly to collaborate in trial of empagliflozin for chronic kidney disease
Gene Johnson | Feb 25, 2017

Combination therapy targets lung cancer
Carol Ostrow | Feb 19, 2017

Partnership spurs efforts against COPD
+ Community
Amanda Rupp | Jun 28, 2016

Boehringer Ingelheim board of managing directors introduces new member
+ Technology/Innovation
Amanda Rupp | Jun 5, 2016

Boehringer Ingelheim, Inventiva collaborate for idiopathic pulmonary fibrosis treatments
+ Technology/Innovation
Amanda Rupp | May 31, 2016

Boehringer Ingelheim to increase HIV/AIDS medication access
+ Technology/Innovation
Amanda Rupp | May 25, 2016

BioMed X, Boehringer Ingelheim partner for psychiatric treatments

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes